SecBot SecBot
SECBOTREPLAY Home › Report › KR

KR · In the Generic Pharmaceuticals MDL 2724 antitrust litigation, the court…

KROGER CO · COURT-RULING filed Mar 1, 2026 at 19:00 ET

At the news

NEUTRALIMPACT 4/10

COURT-RULING filed Mar 1, 2026 at 19:00 ET

In the Generic Pharmaceuticals MDL 2724 antitrust litigation, the court denied Epic Pharma's motions to dismiss claims against it in eight of eleven complaints, including the one filed by The Kroger Co. The Kroger complaint survived because it sufficiently alleged Epic conspired with Lannett and Actavis to fix prices of Ursodiol, including a 1000% price increase by Epic. This ruling keeps Kroger's antitrust claims alive, preserving the potential for damages recovery, but is an interlocutory procedural ruling, not a final judgment, so no damages have been awarded.

  • Kroger is one of 11 plaintiffs in the Generic Pharmaceuticals MDL 2724 antitrust litigation against Epic Pharma.
  • The court denied Epic's motion to dismiss Kroger's complaint, allowing the case to proceed.
  • Kroger's complaint alleges Epic conspired with Lannett and Actavis to raise Ursodiol prices, including a 1000% price increase by Epic.
  • Three other complaints (HCSC, Molina, CVS) were dismissed for failing to adequately plead Epic's involvement.

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access